Global Medical Nuclide Products Market Research Report 2026(Status and Outlook)

May 2026 | 156 pages | ID: GF03F69AEE79EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Medical nuclide products refer to medical preparations or devices containing radioactive isotopes, which achieve diagnostic or therapeutic functions through the radiation released by their decay. Such products must strictly comply with radioactive safety standards and are widely used in the field of nuclear medicine. For example, imaging agents used in diagnosis assist in disease detection through gamma-ray imaging, and iodine-131 and lutetium-177 used in treatment destroy diseased tissues through targeted radiation. Their production, quality control and clinical use are subject to the dual constraints of national nuclear safety regulations and the drug regulatory system to ensure patient safety and the effectiveness of diagnosis and treatment.The global medical nuclide products market is being driven by the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions, which require precise diagnostic imaging and targeted radiopharmaceutical therapies. Technological advancements in nuclear imaging modalities like PET and SPECT, combined with the increasing adoption of theranostic approaches, have significantly expanded clinical applications for medical nuclides. In addition, favorable government initiatives to promote nuclear medicine infrastructure, and increasing investment in radioisotope production facilities, particularly in developing regions, are further accelerating market growth.Despite its potential, the medical nuclide products market faces several challenges. The short half-life of many radioisotopes requires localized and timely production, which puts pressure on logistics and supply chain networks, especially in geographically dispersed regions. Regulatory complexities surrounding the handling, transport, and storage of radioactive materials also increase operational burden. Moreover, a global shortage of key isotopes like Mo-99, and limited access to cyclotrons and nuclear reactors in many countries, hampers consistent supply. High costs and the scarcity of trained nuclear medicine professionals further constrain market expansion in certain areas.

The global Medical Nuclide Products market size was estimated at USD 9552.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Medical Nuclide Products market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Medical Nuclide Products market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Medical Nuclide Products market.

Global Medical Nuclide Products Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

  • Cardinal Health
  • GE Healthcare
  • Lantheus Medical Imaging
  • Bayer
  • Eli Lilly
  • Bracco Imaging
  • Curium Pharma
  • Jubilant Pharmova
  • Aurobindo Pharma
  • Novartis
  • Siemens
  • NTP Radioisotopes
  • ANSTO
  • Polatom
  • China Isotope & Radiation
  • Yantai Dongcheng Pharmaceutical
  • Saide Biotechnology

Market Segmentation (by Type)

  • Technetium-99m
  • Fluorine-18
  • Gallium-68
  • Iodine-123
  • Indium-111
  • Copper-64
  • Xenon-133
  • Iodine-131
  • Yttrium-90
  • Lutetium-177
  • by Application

Market Segmentation (by Application)

  • Cancer
  • Cardiovascular Disease
  • Bone and Joint Disease
  • Other

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Medical Nuclide Products Market

Overview of the regional outlook of the Medical Nuclide Products Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Medical Nuclide Products Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Medical Nuclide Products, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Medical Nuclide Products
1.2 Key Market Segments
  1.2.1 Medical Nuclide Products Segment by Type
  1.2.2 Medical Nuclide Products Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MEDICAL NUCLIDE PRODUCTS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Medical Nuclide Products Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Medical Nuclide Products Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MEDICAL NUCLIDE PRODUCTS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Medical Nuclide Products Product Life Cycle
3.3 Global Medical Nuclide Products Sales by Manufacturers (2020-2025)
3.4 Global Medical Nuclide Products Revenue Market Share by Manufacturers (2020-2025)
3.5 Medical Nuclide Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Medical Nuclide Products Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Medical Nuclide Products Market Competitive Situation and Trends
  3.8.1 Medical Nuclide Products Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Medical Nuclide Products Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MEDICAL NUCLIDE PRODUCTS INDUSTRY CHAIN ANALYSIS

4.1 Medical Nuclide Products Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MEDICAL NUCLIDE PRODUCTS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Medical Nuclide Products Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Medical Nuclide Products Market
5.7 ESG Ratings of Leading Companies

6 MEDICAL NUCLIDE PRODUCTS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Medical Nuclide Products Sales Market Share by Type (2020-2025)
6.3 Global Medical Nuclide Products Market Size by Type (2020-2025)
6.4 Global Medical Nuclide Products Price by Type (2020-2025)

7 MEDICAL NUCLIDE PRODUCTS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Medical Nuclide Products Market Sales by Application (2020-2025)
7.3 Global Medical Nuclide Products Market Size (M USD) by Application (2020-2025)
7.4 Global Medical Nuclide Products Sales Growth Rate by Application (2020-2025)

8 MEDICAL NUCLIDE PRODUCTS MARKET SALES BY REGION

8.1 Global Medical Nuclide Products Sales by Region
  8.1.1 Global Medical Nuclide Products Sales by Region
  8.1.2 Global Medical Nuclide Products Sales Market Share by Region
8.2 Global Medical Nuclide Products Market Size by Region
  8.2.1 Global Medical Nuclide Products Market Size by Region
  8.2.2 Global Medical Nuclide Products Market Size by Region
8.3 North America
  8.3.1 North America Medical Nuclide Products Sales by Country
  8.3.2 North America Medical Nuclide Products Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Medical Nuclide Products Sales by Country
  8.4.2 Europe Medical Nuclide Products Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Medical Nuclide Products Sales by Region
  8.5.2 Asia Pacific Medical Nuclide Products Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Medical Nuclide Products Sales by Country
  8.6.2 South America Medical Nuclide Products Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Medical Nuclide Products Sales by Region
  8.7.2 Middle East and Africa Medical Nuclide Products Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 MEDICAL NUCLIDE PRODUCTS MARKET PRODUCTION BY REGION

9.1 Global Production of Medical Nuclide Products by Region(2020-2025)
9.2 Global Medical Nuclide Products Revenue Market Share by Region (2020-2025)
9.3 Global Medical Nuclide Products Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Medical Nuclide Products Production
  9.4.1 North America Medical Nuclide Products Production Growth Rate (2020-2025)
  9.4.2 North America Medical Nuclide Products Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Medical Nuclide Products Production
  9.5.1 Europe Medical Nuclide Products Production Growth Rate (2020-2025)
  9.5.2 Europe Medical Nuclide Products Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Medical Nuclide Products Production (2020-2025)
  9.6.1 Japan Medical Nuclide Products Production Growth Rate (2020-2025)
  9.6.2 Japan Medical Nuclide Products Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Medical Nuclide Products Production (2020-2025)
  9.7.1 China Medical Nuclide Products Production Growth Rate (2020-2025)
  9.7.2 China Medical Nuclide Products Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Cardinal Health
  10.1.1 Cardinal Health Basic Information
  10.1.2 Cardinal Health Medical Nuclide Products Product Overview
  10.1.3 Cardinal Health Medical Nuclide Products Product Market Performance
  10.1.4 Cardinal Health Business Overview
  10.1.5 Cardinal Health SWOT Analysis
  10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
  10.2.1 GE Healthcare Basic Information
  10.2.2 GE Healthcare Medical Nuclide Products Product Overview
  10.2.3 GE Healthcare Medical Nuclide Products Product Market Performance
  10.2.4 GE Healthcare Business Overview
  10.2.5 GE Healthcare SWOT Analysis
  10.2.6 GE Healthcare Recent Developments
10.3 Lantheus Medical Imaging
  10.3.1 Lantheus Medical Imaging Basic Information
  10.3.2 Lantheus Medical Imaging Medical Nuclide Products Product Overview
  10.3.3 Lantheus Medical Imaging Medical Nuclide Products Product Market Performance
  10.3.4 Lantheus Medical Imaging Business Overview
  10.3.5 Lantheus Medical Imaging SWOT Analysis
  10.3.6 Lantheus Medical Imaging Recent Developments
10.4 Bayer
  10.4.1 Bayer Basic Information
  10.4.2 Bayer Medical Nuclide Products Product Overview
  10.4.3 Bayer Medical Nuclide Products Product Market Performance
  10.4.4 Bayer Business Overview
  10.4.5 Bayer Recent Developments
10.5 Eli Lilly
  10.5.1 Eli Lilly Basic Information
  10.5.2 Eli Lilly Medical Nuclide Products Product Overview
  10.5.3 Eli Lilly Medical Nuclide Products Product Market Performance
  10.5.4 Eli Lilly Business Overview
  10.5.5 Eli Lilly Recent Developments
10.6 Bracco Imaging
  10.6.1 Bracco Imaging Basic Information
  10.6.2 Bracco Imaging Medical Nuclide Products Product Overview
  10.6.3 Bracco Imaging Medical Nuclide Products Product Market Performance
  10.6.4 Bracco Imaging Business Overview
  10.6.5 Bracco Imaging Recent Developments
10.7 Curium Pharma
  10.7.1 Curium Pharma Basic Information
  10.7.2 Curium Pharma Medical Nuclide Products Product Overview
  10.7.3 Curium Pharma Medical Nuclide Products Product Market Performance
  10.7.4 Curium Pharma Business Overview
  10.7.5 Curium Pharma Recent Developments
10.8 Jubilant Pharmova
  10.8.1 Jubilant Pharmova Basic Information
  10.8.2 Jubilant Pharmova Medical Nuclide Products Product Overview
  10.8.3 Jubilant Pharmova Medical Nuclide Products Product Market Performance
  10.8.4 Jubilant Pharmova Business Overview
  10.8.5 Jubilant Pharmova Recent Developments
10.9 Aurobindo Pharma
  10.9.1 Aurobindo Pharma Basic Information
  10.9.2 Aurobindo Pharma Medical Nuclide Products Product Overview
  10.9.3 Aurobindo Pharma Medical Nuclide Products Product Market Performance
  10.9.4 Aurobindo Pharma Business Overview
  10.9.5 Aurobindo Pharma Recent Developments
10.10 Novartis
  10.10.1 Novartis Basic Information
  10.10.2 Novartis Medical Nuclide Products Product Overview
  10.10.3 Novartis Medical Nuclide Products Product Market Performance
  10.10.4 Novartis Business Overview
  10.10.5 Novartis Recent Developments
10.11 Siemens
  10.11.1 Siemens Basic Information
  10.11.2 Siemens Medical Nuclide Products Product Overview
  10.11.3 Siemens Medical Nuclide Products Product Market Performance
  10.11.4 Siemens Business Overview
  10.11.5 Siemens Recent Developments
10.12 NTP Radioisotopes
  10.12.1 NTP Radioisotopes Basic Information
  10.12.2 NTP Radioisotopes Medical Nuclide Products Product Overview
  10.12.3 NTP Radioisotopes Medical Nuclide Products Product Market Performance
  10.12.4 NTP Radioisotopes Business Overview
  10.12.5 NTP Radioisotopes Recent Developments
10.13 ANSTO
  10.13.1 ANSTO Basic Information
  10.13.2 ANSTO Medical Nuclide Products Product Overview
  10.13.3 ANSTO Medical Nuclide Products Product Market Performance
  10.13.4 ANSTO Business Overview
  10.13.5 ANSTO Recent Developments
10.14 Polatom
  10.14.1 Polatom Basic Information
  10.14.2 Polatom Medical Nuclide Products Product Overview
  10.14.3 Polatom Medical Nuclide Products Product Market Performance
  10.14.4 Polatom Business Overview
  10.14.5 Polatom Recent Developments
10.15 China Isotope and Radiation
  10.15.1 China Isotope and Radiation Basic Information
  10.15.2 China Isotope and Radiation Medical Nuclide Products Product Overview
  10.15.3 China Isotope and Radiation Medical Nuclide Products Product Market Performance
  10.15.4 China Isotope and Radiation Business Overview
  10.15.5 China Isotope and Radiation Recent Developments
10.16 Yantai Dongcheng Pharmaceutical
  10.16.1 Yantai Dongcheng Pharmaceutical Basic Information
  10.16.2 Yantai Dongcheng Pharmaceutical Medical Nuclide Products Product Overview
  10.16.3 Yantai Dongcheng Pharmaceutical Medical Nuclide Products Product Market Performance
  10.16.4 Yantai Dongcheng Pharmaceutical Business Overview
  10.16.5 Yantai Dongcheng Pharmaceutical Recent Developments
10.17 Saide Biotechnology
  10.17.1 Saide Biotechnology Basic Information
  10.17.2 Saide Biotechnology Medical Nuclide Products Product Overview
  10.17.3 Saide Biotechnology Medical Nuclide Products Product Market Performance
  10.17.4 Saide Biotechnology Business Overview
  10.17.5 Saide Biotechnology Recent Developments

11 MEDICAL NUCLIDE PRODUCTS MARKET FORECAST BY REGION

11.1 Global Medical Nuclide Products Market Size Forecast
11.2 Global Medical Nuclide Products Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Medical Nuclide Products Market Size Forecast by Country
  11.2.3 Asia Pacific Medical Nuclide Products Market Size Forecast by Region
  11.2.4 South America Medical Nuclide Products Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Medical Nuclide Products by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Medical Nuclide Products Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Medical Nuclide Products by Type (2026-2035)
  12.1.2 Global Medical Nuclide Products Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Medical Nuclide Products by Type (2026-2035)
12.2 Global Medical Nuclide Products Market Forecast by Application (2026-2035)
  12.2.1 Global Medical Nuclide Products Sales (K MT) Forecast by Application
  12.2.2 Global Medical Nuclide Products Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Medical Nuclide Products Market Size by Type (M USD)
Table 4. Global Medical Nuclide Products Market Size by Application
Table 5. Medical Nuclide Products Market Size Comparison by Region (M USD)
Table 6. Global Medical Nuclide Products Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Medical Nuclide Products Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Medical Nuclide Products Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Medical Nuclide Products Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Nuclide Products as of 2025)
Table 11. Global Market Medical Nuclide Products Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Medical Nuclide Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Medical Nuclide Products Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Medical Nuclide Products Sales by Type (K MT)
Table 27. Global Medical Nuclide Products Market Size by Type (M USD)
Table 28. Global Medical Nuclide Products Sales (K MT) by Type (2020-2025)
Table 29. Global Medical Nuclide Products Sales Market Share by Type (2020-2025)
Table 30. Global Medical Nuclide Products Market Size (M USD) by Type (2020-2025)
Table 31. Global Medical Nuclide Products Market Share by Type (2020-2025)
Table 32. Global Medical Nuclide Products Price (USD/KG) by Type (2020-2025)
Table 33. Global Medical Nuclide Products Sales (K MT) by Application
Table 34. Global Medical Nuclide Products Market Size by Application
Table 35. Global Medical Nuclide Products Sales by Application (2020-2025) & (K MT)
Table 36. Global Medical Nuclide Products Sales Market Share by Application (2020-2025)
Table 37. Global Medical Nuclide Products Market Size by Application (2020-2025) & (M USD)
Table 38. Global Medical Nuclide Products Market Share by Application (2020-2025)
Table 39. Global Medical Nuclide Products Sales Growth Rate by Application (2020-2025)
Table 40. Global Medical Nuclide Products Sales by Region (2020-2025) & (K MT)
Table 41. Global Medical Nuclide Products Sales Market Share by Region (2020-2025)
Table 42. Global Medical Nuclide Products Market Size by Region (2020-2025) & (M USD)
Table 43. Global Medical Nuclide Products Market Size by Region (2020-2025)
Table 44. North America Medical Nuclide Products Sales by Country (2020-2025) & (K MT)
Table 45. North America Medical Nuclide Products Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Medical Nuclide Products Sales by Country (2020-2025) & (K MT)
Table 47. Europe Medical Nuclide Products Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Medical Nuclide Products Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Medical Nuclide Products Market Size by Region (2020-2025) & (M USD)
Table 50. South America Medical Nuclide Products Sales by Country (2020-2025) & (K MT)
Table 51. South America Medical Nuclide Products Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Medical Nuclide Products Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Medical Nuclide Products Market Size by Region (2020-2025) & (M USD)
Table 54. Global Medical Nuclide Products Production (K MT) by Region(2020-2025)
Table 55. Global Medical Nuclide Products Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Medical Nuclide Products Revenue Market Share by Region (2020-2025)
Table 57. Global Medical Nuclide Products Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Medical Nuclide Products Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Medical Nuclide Products Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Medical Nuclide Products Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Medical Nuclide Products Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Medical Nuclide Products Product Overview
Table 64. Cardinal Health Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Medical Nuclide Products Product Overview
Table 70. GE Healthcare Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Lantheus Medical Imaging Basic Information
Table 75. Lantheus Medical Imaging Medical Nuclide Products Product Overview
Table 76. Lantheus Medical Imaging Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lantheus Medical Imaging Business Overview
Table 78. Lantheus Medical Imaging SWOT Analysis
Table 79. Lantheus Medical Imaging Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer Medical Nuclide Products Product Overview
Table 82. Bayer Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. Eli Lilly Basic Information
Table 86. Eli Lilly Medical Nuclide Products Product Overview
Table 87. Eli Lilly Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Recent Developments
Table 90. Bracco Imaging Basic Information
Table 91. Bracco Imaging Medical Nuclide Products Product Overview
Table 92. Bracco Imaging Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bracco Imaging Business Overview
Table 94. Bracco Imaging Recent Developments
Table 95. Curium Pharma Basic Information
Table 96. Curium Pharma Medical Nuclide Products Product Overview
Table 97. Curium Pharma Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Curium Pharma Business Overview
Table 99. Curium Pharma Recent Developments
Table 100. Jubilant Pharmova Basic Information
Table 101. Jubilant Pharmova Medical Nuclide Products Product Overview
Table 102. Jubilant Pharmova Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jubilant Pharmova Business Overview
Table 104. Jubilant Pharmova Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Medical Nuclide Products Product Overview
Table 107. Aurobindo Pharma Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. Novartis Basic Information
Table 111. Novartis Medical Nuclide Products Product Overview
Table 112. Novartis Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Novartis Business Overview
Table 114. Novartis Recent Developments
Table 115. Siemens Basic Information
Table 116. Siemens Medical Nuclide Products Product Overview
Table 117. Siemens Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Siemens Business Overview
Table 119. Siemens Recent Developments
Table 120. NTP Radioisotopes Basic Information
Table 121. NTP Radioisotopes Medical Nuclide Products Product Overview
Table 122. NTP Radioisotopes Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. NTP Radioisotopes Business Overview
Table 124. NTP Radioisotopes Recent Developments
Table 125. ANSTO Basic Information
Table 126. ANSTO Medical Nuclide Products Product Overview
Table 127. ANSTO Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. ANSTO Business Overview
Table 129. ANSTO Recent Developments
Table 130. Polatom Basic Information
Table 131. Polatom Medical Nuclide Products Product Overview
Table 132. Polatom Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Polatom Business Overview
Table 134. Polatom Recent Developments
Table 135. China Isotope and Radiation Basic Information
Table 136. China Isotope and Radiation Medical Nuclide Products Product Overview
Table 137. China Isotope and Radiation Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. China Isotope and Radiation Business Overview
Table 139. China Isotope and Radiation Recent Developments
Table 140. Yantai Dongcheng Pharmaceutical Basic Information
Table 141. Yantai Dongcheng Pharmaceutical Medical Nuclide Products Product Overview
Table 142. Yantai Dongcheng Pharmaceutical Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Yantai Dongcheng Pharmaceutical Business Overview
Table 144. Yantai Dongcheng Pharmaceutical Recent Developments
Table 145. Saide Biotechnology Basic Information
Table 146. Saide Biotechnology Medical Nuclide Products Product Overview
Table 147. Saide Biotechnology Medical Nuclide Products Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Saide Biotechnology Business Overview
Table 149. Saide Biotechnology Recent Developments
Table 150. Global Medical Nuclide Products Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Medical Nuclide Products Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Medical Nuclide Products Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Medical Nuclide Products Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Medical Nuclide Products Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Medical Nuclide Products Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Medical Nuclide Products Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Medical Nuclide Products Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Medical Nuclide Products Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Medical Nuclide Products Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Medical Nuclide Products Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Medical Nuclide Products Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Medical Nuclide Products Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Medical Nuclide Products Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Medical Nuclide Products Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Medical Nuclide Products Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Medical Nuclide Products Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Medical Nuclide Products
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Medical Nuclide Products Market Size (M USD), 2025-2035
Figure 5. Global Medical Nuclide Products Market Size (M USD) (2020-2035)
Figure 6. Global Medical Nuclide Products Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Medical Nuclide Products Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Medical Nuclide Products Product Life Cycle
Figure 13. Medical Nuclide Products Sales Share by Manufacturers in 2025
Figure 14. Global Medical Nuclide Products Revenue Share by Manufacturers in 2025
Figure 15. Medical Nuclide Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Medical Nuclide Products Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Medical Nuclide Products Revenue in 2025
Figure 18. Industry Chain Map of Medical Nuclide Products
Figure 19. Global Medical Nuclide Products Market PEST Analysis
Figure 20. Global Medical Nuclide Products Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Medical Nuclide Products Market Share by Type
Figure 27. Sales Market Share of Medical Nuclide Products by Type (2020-2025)
Figure 28. Sales Market Share of Medical Nuclide Products by Type in 2025
Figure 29. Market Share of Medical Nuclide Products by Type (2020-2025)
Figure 30. Market Share of Medical Nuclide Products by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Medical Nuclide Products Market Share by Application
Figure 33. Global Medical Nuclide Products Sales Market Share by Application (2020-2025)
Figure 34. Global Medical Nuclide Products Sales Market Share by Application in 2025
Figure 35. Global Medical Nuclide Products Market Share by Application (2020-2025)
Figure 36. Global Medical Nuclide Products Market Share by Application in 2025
Figure 37. Global Medical Nuclide Products Sales Growth Rate by Application (2020-2025)
Figure 38. Global Medical Nuclide Products Sales Market Share by Region (2020-2025)
Figure 39. Global Medical Nuclide Products Market Size by Region (2020-2025)
Figure 40. North America Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Medical Nuclide Products Sales Market Share by Country in 2024
Figure 43. North America Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Medical Nuclide Products Market Size by Country in 2024
Figure 45. U.S. Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Medical Nuclide Products Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Medical Nuclide Products Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Medical Nuclide Products Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Medical Nuclide Products Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Medical Nuclide Products Sales Market Share by Country in 2024
Figure 53. Europe Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Medical Nuclide Products Market Size by Country in 2024
Figure 55. Germany Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Medical Nuclide Products Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Medical Nuclide Products Sales Market Share by Region in 2024
Figure 67. Asia Pacific Medical Nuclide Products Market Size by Region in 2024
Figure 68. China Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Medical Nuclide Products Sales and Growth Rate (K MT)
Figure 79. South America Medical Nuclide Products Sales Market Share by Country in 2024
Figure 80. South America Medical Nuclide Products Market Size and Growth Rate (M USD)
Figure 81. South America Medical Nuclide Products Market Size by Country in 2024
Figure 82. Brazil Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Medical Nuclide Products Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Medical Nuclide Products Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Medical Nuclide Products Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Medical Nuclide Products Market Size by Region in 2024
Figure 92. Saudi Arabia Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Medical Nuclide Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Medical Nuclide Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Medical Nuclide Products Production Market Share by Region (2020-2025)
Figure 103. North America Medical Nuclide Products Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Medical Nuclide Products Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Medical Nuclide Products Production (K MT) Growth Rate (2020-2025)
Figure 106. China Medical Nuclide Products Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Medical Nuclide Products Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Medical Nuclide Products Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Medical Nuclide Products Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Medical Nuclide Products Market Share Forecast by Type (2026-2035)
Figure 111. Global Medical Nuclide Products Sales Forecast by Application (2026-2035)
Figure 112. Global Medical Nuclide Products Market Share Forecast by Application (2026-2035)